Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?-Reference-Cited by-同舟云学术

Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?

Published:2009-07-15 Issue:9 Volume:13 Page:1105-1120
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Memtsas Vassilios,Zarros Apostolos,Theocharis Stamatios

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728220903136767

Reference162 articles.

1. How Matrix Metalloproteinases Regulate Cell Behavior

2. New functions for the matrix metalloproteinases in cancer progression

3. Changing views of the role of matrix metalloproteinases in metastasis

4. MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Holistic Appraisal of Stromal Differentiation in Colorectal Cancer: Biology, Histopathology, Computation, and Genomics;Pathology - Research and Practice;2021-04

2. Polymorphisms in MMP-14 and MMP-2 genes and ovarian cancer survival;Cancer Biomarkers;2019-07-23

3. Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer;Pathology - Research and Practice;2019-06

4. MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer;Journal of Ovarian Research;2016-09-02

5. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer;Diagnostic Pathology;2016-04-02